Navigation Links
Sangamo BioSciences Reports Second Quarter 2013 Financial Results
Date:7/24/2013

RICHMOND, Calif., July 24, 2013 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) today reported second quarter 2013 financial results and accomplishments.

(Logo: http://photos.prnewswire.com/prnh/20130102/SF35903LOGO)

For the second quarter ended June 30, 2013, Sangamo reported a consolidated net loss of $5.5 million, or $0.10 per share, compared to a net loss of $5.7 million, or $0.11 per share, for the same period in 2012. As of June 30, 2013, the company had cash, cash equivalents, marketable securities and interest receivable of $66.4 million.

Revenues for the second quarter of 2013 were $6.9 million, compared to $4.6 million for the same period in 2012. Second quarter 2013 revenues were generated from the Company's collaboration agreements with Shire AG (Shire) and Sigma-Aldrich Corporation, and research grants. The revenues recognized for the second quarter of 2013 consisted of $6.2 million in collaboration agreements and approximately $0.8 million in research grants, compared to $3.8 million and $0.8 million, respectively, for the same period in 2012.

The increase in collaboration agreement revenues was primarily due to the Company's collaboration and license agreement with Shire established in January 2012. Pursuant to the agreement, Sangamo received an upfront payment of $13.0 million, which is being amortized on a straight-line basis over the initial six-year research term, of which the Company recognized $0.5 million as revenue for the second quarter of 2013. Sangamo also recognized $4.2 million of revenues related to research services performed under the collaboration agreement with Shire in the second quarter.

Research and development expenses were $9.3 million for the second quarter of 2013, compared to $7.6 million for the
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Sangamo BioSciences Announces Publication of First Demonstration of Inactivation of Extra Chromosome Responsible for Down Syndrome
2. Sangamo BioSciences Announces Second Quarter 2013 Conference Call And Webcast
3. Sangamo BioSciences Reports First Quarter 2013 Financial Results
4. Sangamo BioSciences Announces First Quarter 2013 Conference Call and Webcast
5. Sangamo BioSciences Announces Presentation At The Barclays Global Healthcare Conference
6. Sangamo BioSciences Announces Presentation At 33rd Annual Cowen And Company Health Care Conference
7. Sangamo BioSciences Reports Fourth Quarter And Full Year 2012 Financial Results
8. Sangamo BioSciences to Webcast Analyst Briefing on Thursday, December 6, 2012
9. Sangamo BioSciences Reports Second Quarter 2012 Financial Results
10. 3-V Biosciences Completes $20 Million Series C Financing
11. New BD Biosciences Flow Cytometry Cell Analyzer Enables Complex Multicolor Experiments in Disease Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... Dec. 15, 2014  Inovio Pharmaceuticals, Inc. (NASDAQ: ... been added to the NASDAQ Biotechnology Index (NBI). ... become effective upon market open on December 22, ... designed to track the performance of a set ... biotechnology or pharmaceutical according to the Industry Classification ...
(Date:12/15/2014)... , Dec. 15, 2014  Stephen Squires, CEO ... Quantum Materials Corp (OTCQB:QTMM), will be speaking ... Quantum Materials (RCQM) on December 16th, 2014. The RCQM ... exotic nanomaterials in attracting top faculty and students and ... collaborate on research. "We have a ...
(Date:12/13/2014)... Dec. 11, 2014 Research and Markets ... of the "Drug Injection Devices to 2020" ... http://photos.prnewswire.com/prnh/20130307/600769 As new ... expanding list of health conditions, drug developers have ... the administration process and increase the efficiency and ...
Breaking Medicine Technology:Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index 2Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index 3Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index 4Quantum Materials CEO Stephen Squires to Speak at Rice Center for Quantum Materials Launch 2Quantum Materials CEO Stephen Squires to Speak at Rice Center for Quantum Materials Launch 3Drug Injection Devices to 2020 2Drug Injection Devices to 2020 3Drug Injection Devices to 2020 4
... Giaconda Ltd (ASX: GIA) today,announced that the US ... Investigational New Drug application (IND),for the clinical development ... with Mycobacterium avium spp,paratuberculosis (MAP). , ,The Company ... therapy to be submitted to the FDA for ...
... 2007 /PRNewswire-FirstCall/ --,Allos Therapeutics, Inc. today announced ... a favorable opinion of the Committee for,Orphan ... (EMEA),has granted orphan drug designation to the ... of patients with,peripheral T-cell lymphoma (PTCL). In ...
Cached Medicine Technology:FDA approves MyocondaR IND for MAP in Crohn's Disease 2FDA approves MyocondaR IND for MAP in Crohn's Disease 3FDA approves MyocondaR IND for MAP in Crohn's Disease 4Allos Therapeutics' PDX Granted Orphan Medicinal Product,Designation by the European Commission 2Allos Therapeutics' PDX Granted Orphan Medicinal Product,Designation by the European Commission 3Allos Therapeutics' PDX Granted Orphan Medicinal Product,Designation by the European Commission 4
(Date:12/17/2014)... gas prices rose in recent years, so did motorcyclist ... times of gas increases, more people start using motorcycles ... explained. They examined data gathered between 2002 and ... motorcycle registrations in the United States and the third ... a strong association between rising gas prices and an ...
(Date:12/17/2014)... News) -- Greater participation in music classes may benefit ... followed kids in the nonprofit Harmony Project, which provides ... Angeles. Over two years, children who actively participated ... brain processes speech and reading, compared to those with ... active participation in music classes occurred in the same ...
(Date:12/15/2014)... 2014 A recent survey found that ... as impacting skin health and beauty were: “Connections,” “climate,” ... care.” Water and health advocate and radio host Sharon ... describing the survey and the Four C’s.* Kleyne notes, ... category discussed would benefit from paying attention to one’s ...
(Date:12/15/2014)... Beach, FL (PRWEB) December 15, 2014 South ... , knows that holidays can be a daze of hassle, ... slips and falls while decking halls, to burns when making ... of holiday hazards that can happen at any time. To ... pain, MD Now has made a list of helpful and ...
(Date:12/15/2014)... Steven Reinberg HealthDay Reporter ... study should reassure the millions of American women who have ... cancer. "There is no association between migraine and breast ... of medicine at Harvard Medical School. "There is no positive ... is no protective effect either." About 18 percent of ...
Breaking Medicine News(10 mins):Health News:When Gas Prices Go Up, So Do Motorcycle Accidents, Study Finds 2Health News:Music Classes Boost Language Skills, Study Says 2Health News:Water and health advocate Sharon Kleyne adds a “W” for fresh water to “four C’s of skin care” 2Health News:Water and health advocate Sharon Kleyne adds a “W” for fresh water to “four C’s of skin care” 3Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News: No Link Between Migraine, Breast Cancer Risk, Study Says 2
... ... ... Professions, in partnership with the Nassau County (N.Y.) Department of Health, will hold a H1N1 ... for all members of the NYIT community and their families, as well residents of the ...
... ... received approval for re-accreditation by the American College of Radiology (ACR) , ... Berkeley Heights (Vocus) February 2, ... American College of Radiology (ACR) for the period of January 2010 through January 2013. ...
... ... List , ... Ariz. (Vocus) February 2, 2010 -- A Tucson retirement community’s health center, Sonora at ... and World Report. The designation will appear in the national magazine’s February 2010 issue. ...
... , , , , BEIJING ... ( SVA),("Sinovac" or the "Company"), a leading China -based ... offering was,closed on February 2, 2010 . Sinovac received ... discounts and commissions and,estimated offering expenses payable by the Company, ...
... , , A new free ... residents save money on their medications at most pharmacies within the state. ... The Saints are going to the Super Bowl and we ... for our fellow Louisiana residents and offer the free drug ...
... ... in Next Two Years, According to New Report , ... La Jolla, Calif. (Vocus) February 2, 2010 -- The biomedical industry ... of innovation, job growth and revenue that will help lead the state to economic recovery, ...
Cached Medicine News:Health News:Nuclear Medicine at Summit Medical Group Earns ACR Re-Accreditation 2Health News:U.S. News & World Report Ranks Sonora at Splendido Among Top in Nation 2Health News:Sinovac Announces Closing of Common Share Offering 2Health News:Sinovac Announces Closing of Common Share Offering 3Health News:Who Dat Got Dem Free Drug Cards? 2Health News:Biomedical Industry Jobs Critical to California's Economic Recovery, Finds California Healthcare Institute and PricewaterhouseCoopers 2Health News:Biomedical Industry Jobs Critical to California's Economic Recovery, Finds California Healthcare Institute and PricewaterhouseCoopers 3Health News:Biomedical Industry Jobs Critical to California's Economic Recovery, Finds California Healthcare Institute and PricewaterhouseCoopers 4Health News:Biomedical Industry Jobs Critical to California's Economic Recovery, Finds California Healthcare Institute and PricewaterhouseCoopers 5Health News:Biomedical Industry Jobs Critical to California's Economic Recovery, Finds California Healthcare Institute and PricewaterhouseCoopers 6Health News:Biomedical Industry Jobs Critical to California's Economic Recovery, Finds California Healthcare Institute and PricewaterhouseCoopers 7
...
...
Ascent Primary Knee System with cruciate retaining, posterior stabilized and constrained components...
Ascent Primary Knee System with cruciate retaining, posterior stabilized and constrained components...
Medicine Products: